[go: up one dir, main page]

PL2497486T3 - Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi - Google Patents

Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Info

Publication number
PL2497486T3
PL2497486T3 PL12170750T PL12170750T PL2497486T3 PL 2497486 T3 PL2497486 T3 PL 2497486T3 PL 12170750 T PL12170750 T PL 12170750T PL 12170750 T PL12170750 T PL 12170750T PL 2497486 T3 PL2497486 T3 PL 2497486T3
Authority
PL
Poland
Prior art keywords
qualitative
changes
diseases caused
treating diseases
quantitative composition
Prior art date
Application number
PL12170750T
Other languages
English (en)
Inventor
Dmitry Dmitrievich Genkin
Victor Veniaminovich Tets
Georgy Victorovich Tets
Original Assignee
Cls Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/RU2003/000304 external-priority patent/WO2005007187A1/ru
Application filed by Cls Therapeutics Ltd filed Critical Cls Therapeutics Ltd
Publication of PL2497486T3 publication Critical patent/PL2497486T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12170750T 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi PL2497486T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/RU2003/000304 WO2005007187A1 (en) 2003-07-14 2003-07-14 Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment
RU2004108057/14A RU2269358C2 (ru) 2003-07-14 2004-03-12 Способ лечения генерализованных инфекций, вызываемых бактериями, или заболеваний, вызываемых грибами и простейшими, или атеросклероза, или сахарного диабета, или заболеваний, связанных с реакцией гиперчувствительности замедленного типа, или заболеваний, обусловленных мутациями генов соматических клеток
EP12170750.9A EP2497486B1 (en) 2003-07-14 2004-07-01 Method for treating diseases caused by fungi associated with changes of qualitative and/quantitative composition of blood extracellular DNA
EP04775224A EP1661579B1 (en) 2003-07-14 2004-07-01 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna

Publications (1)

Publication Number Publication Date
PL2497486T3 true PL2497486T3 (pl) 2014-01-31

Family

ID=34067506

Family Applications (4)

Application Number Title Priority Date Filing Date
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi

Country Status (6)

Country Link
US (1) US20070104702A1 (pl)
EP (4) EP2497488B1 (pl)
ES (4) ES2388605T3 (pl)
PL (4) PL2497488T3 (pl)
RU (1) RU2269358C2 (pl)
WO (1) WO2005004789A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
EP1880733A4 (en) * 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich METHOD FOR EXTENDING THE LIFE OF A HUMAN AND ANIMALS
JP5372769B2 (ja) 2006-11-28 2013-12-18 シーエルエス セラピューティック リミティド 組織の細胞外間隙においてデオキシリボ核酸の量が増量することに関連するヒトの病気の治療方法及び該方法を実施するための医薬製剤
CN102333522A (zh) * 2009-10-16 2012-01-25 莱富凯尔创新私人有限公司 用于治疗真菌感染的含胆固醇的脂质体两性霉素的制剂
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
ES2799515T3 (es) 2015-05-22 2020-12-18 Dmitry Dmitrievich Genkin ADN extracelular como una diana terapéutica en la neurodegeneración
AU2019209770B2 (en) 2018-01-16 2025-07-31 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
FR2666096B1 (fr) * 1990-08-21 1993-12-31 Sfri Sa Nouveau procede de dosage d'acide desoxyribonucleique present en position extracellulaire dans un milieu.
US5484589A (en) * 1992-04-20 1996-01-16 Rufeld, Inc. Anti-viral methods using RNAse and DNAse
WO1997028266A1 (en) * 1996-02-05 1997-08-07 Genentech, Inc. Human dnase resistant to actin inhibition
US6391607B1 (en) 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
WO2005007187A1 (en) * 2003-07-14 2005-01-27 Viktor Veniaminovich Tets Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment

Also Published As

Publication number Publication date
US20070104702A1 (en) 2007-05-10
EP1661579A2 (en) 2006-05-31
EP2497488A1 (en) 2012-09-12
WO2005004789A2 (en) 2005-01-20
EP1661579A4 (en) 2009-11-25
EP2497487A1 (en) 2012-09-12
RU2004108057A (ru) 2005-09-27
EP2497486B1 (en) 2013-08-07
PL2497487T3 (pl) 2014-01-31
EP2497486A1 (en) 2012-09-12
PL2497488T3 (pl) 2014-01-31
WO2005004789A3 (en) 2005-03-24
EP2497487B1 (en) 2013-08-07
ES2434112T3 (es) 2013-12-13
EP1661579B1 (en) 2012-06-06
PL1661579T3 (pl) 2012-11-30
RU2269358C2 (ru) 2006-02-10
ES2433918T3 (es) 2013-12-13
ES2388605T3 (es) 2012-10-16
EP2497488B1 (en) 2013-08-07
ES2434111T3 (es) 2013-12-13

Similar Documents

Publication Publication Date Title
IL184403A0 (en) Method and composition for treating mammalian diseases and injuries caused by the over expression of peroxynitrite
DE602005008970D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten
IL185256A0 (en) Method and composition for treating peripheral vascular diseases
EP1881823A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
IL177308A0 (en) Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
DE602004010939D1 (de) Methode und Vorrichtung zur menschlichen Stressevaluierung durch Photoplethysmographie
IL180600A0 (en) Compositions and methods of use for treatment of mammalian diseases
IL169602A0 (en) Methods of treating lung diseases
WO2008073177A3 (en) Expression profiles associated with irinotecan treatment
WO2005112981A3 (en) Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
IL183079A0 (en) Method and fluorinated compositions for treating amyloid-related diseases
DE602004032478D1 (de) Eidung und verfahren zur stromlosen metallabscheidung unter verwendung davon
ATE411803T1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
EP2037736A4 (en) METHODS OF TREATING RENAL KYSTIC DISEASES
PL2497486T3 (pl) Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
WO2007087424A3 (en) Method of treating kcnq related disorders using organozinc compounds
EP1709155A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF DYSPROLIFERATIVE DISEASES AND METHODS OF THEIR USE
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
IL178875A0 (en) Method of treating microbial plant diseases
GB0422634D0 (en) Method of treating skin diseases
WO2006132739A3 (en) Novel chemical compounds
EP1787119A4 (en) COMPOSITION FOR ANALYZING SUGAR DIABETES AND / OR RETINAL VASCULAR DISEASE AND METHOD OF ANALYSIS THEREOF
DE602004031691D1 (de) Wässrige Lederbehandlungszusammensetzung und Verfahren zu seiner Verwendung
WO2007067516A3 (en) Multiple myeloma
WO2008014296A3 (en) Composition and method for treatment of tumors